SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615219-17-000030
Filing Date
2017-05-03
Accepted
2017-05-03 08:15:35
Documents
2
Period of Report
2017-05-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K flks201703318-k.htm 8-K 28170
2 EXHIBIT 99.1 flks201703318-kpr.htm EX-99.1 94512
  Complete submission text file 0001615219-17-000030.txt   123808
Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 17807227
SIC: 2834 Pharmaceutical Preparations